Skip to main content
. 2024 Mar 22;40:100887. doi: 10.1016/j.lanepe.2024.100887

Fig. 3.

Fig. 3

Cost-effectiveness of long-term statin therapy in categories by sex, age, pre-treatment LDL cholesterol level and cardiovascular risk. LDL, low density lipoprotein; CVD, cardiovascular disease; ICER, incremental cost-effectiveness ratio with costs and QALYs discounted at 3.5% per year. QALY, quality-adjusted life year; n/a, not applicable. Standard statin achieves 35%–45% LDL cholesterol reduction and higher intensity statin achieves ≥45% LDL cholesterol reduction.